CS Diagnostics (OTC: FZRO) Moves Forward with 2024
Post# of 36482
![](/assets/46931549/no_avatar_available_thumb.jpg)
CS Diagnostics Group (OTC: FZRO) signed a landmark agreement to sell and transfer tangible and intangible assets, including patents, for the CS Protect-Hydrogel to CS Diagnostics Corp. The hydrogel-based tissue spacer, designed for radiation therapy, increases the distance between healthy tissue and cancer cells, protecting healthy tissues from high radiation doses.
Full Details Here https://www.marketscreener.com/quote/stock/CS...-47554520/
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)